Skip to main content

What the label lists and what reports show

Salmeterol side effects

Salmeterol's FDA label: “Most common adverse reactions (incidence ≥5%) are: • Asthma: Headache, influenza, nasal/sinus congestion, pharyngitis, rhinitis, tracheitis/bronchitis.” FAERS holds 8,572 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is dyspnoea (1,259 reports).

  • No generic listed
  • Boxed warning

Check it at the source: the salmeterol FDA label on DailyMed (effective October 10, 2022, GlaxoSmithKline LLC); the FDA FAERS public dashboard.

What does the patient leaflet say about side effects?

From the patient leaflet: What are the possible side effects of SEREVENT DISKUS?

SEREVENT DISKUS can cause serious side effects, including: • See “What is the most important information I should know about SEREVENT DISKUS?” • sudden breathing problems immediately after inhaling your medicine. If you have sudden breathing problems immediately after inhaling your medicine, stop using SEREVENT DISKUS and call your healthcare provider right away. • effects on heart. ο increased blood pressure ο chest pain ο a fast or irregular heartbeat, awareness of heartbeat • effects on nervous system. ο tremor ο nervousness • serious allergic reactions. […]

Source: FDA drug label, GlaxoSmithKline LLC, effective October 10, 2022 (SPL set 12d9728e-6b5c-4aee-bfb0-745e542ed2e4), via openFDA; the full label on DailyMed

What does the label list?

From the label: adverse reactions

Most common adverse reactions (incidence ≥5%) are: • Asthma: Headache, influenza, nasal/sinus congestion, pharyngitis, rhinitis, tracheitis/bronchitis.

Table 3. Adverse Reactions with SEREVENT DISKUS with ≥3% Incidence in U.S. Controlled Clinical Trials in Subjects with Chronic Obstructive Pulmonary Disease a

ReactionAdverse Event SEREVENT DISKUS 50 mcg Twice Daily (n = 341)Percent of Subjects Placebo (n = 576)
Hypertension42
Throat irritation76
Nasal congestion/blockage43
Sinusitis42
Ear signs and symptoms31
Nausea and vomiting33
Cough54
Rhinitis42
Viral respiratory infection54
Musculoskeletal pain1210
Muscle cramps and spasms31
Headache1411
Dizziness42
Average duration of exposure (days)138.5128.9

Rows and numbers as the label prints them, under its own column headings (the first rows of a longer table where it runs on). A reaction in a trial table is not necessarily caused by the medicine, and trials differ from everyday use.

From the label: adverse reactions, continued

LABA, including salmeterol, the active ingredient in SEREVENT DISKUS, as monotherapy (without ICS) increase the risk of asthma-related death. Data from a large 28-week placebo-controlled U.S. trial that compared the safety of salmeterol or placebo added to usual asthma therapy showed an increase in asthma-related deaths in subjects receiving salmeterol. Available data from controlled clinical trials suggest that LABA as monotherapy increase the risk of asthma-related hospitalization in pediatric and adolescent patients [see Warnings and Precautions ( 5.1 ), Clinical Studies ( 14.1 )]. Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice. Most common adverse reactions (incidence ≥5%) are: • Asthma: Headache, influenza, nasal/sinus congestion, pharyngitis, rhinitis, tracheitis/bronchitis. ( 6.1 ) • COPD: Cough, headache, musculoskeletal pain, throat irritation, viral respiratory infection. …

Source: FDA drug label, GlaxoSmithKline LLC, effective October 10, 2022 (SPL set 12d9728e-6b5c-4aee-bfb0-745e542ed2e4), via openFDA; the full label on DailyMed

What do FAERS reports show?

8,572 reports list salmeterol among the medicines taken, each a report of something that happened, not proof the medicine caused it; 960 are coded as a death and 2,485 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 20 reactions below, 10 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.

Reports received each year

The 25 most reported reactions

  • Dyspnoea1,259
  • Drug Ineffective (a use or a product term, not a reaction)1,230
  • Asthma (a use or a product term, not a reaction)912
  • Cough (named in the label)589
  • Headache (named in the label)465
  • Pneumonia408
  • Nausea (named in the label)400
  • Wheezing (named in the label)372
  • Dizziness (named in the label)367
  • Chest Discomfort355
  • Fatigue354
  • Pharmaceutical Product Complaint318
  • Chest Pain (named in the label)308
  • Malaise296
  • Diarrhoea283
  • Pain279
  • Death (an outcome recorded in the report)269
  • Product Quality Issue (a use or a product term, not a reaction)266
  • Chronic Obstructive Pulmonary Disease (a use or a product term, not a reaction)255
  • Vomiting (named in the label)249
  • Anxiety (named in the label)244
  • Dysphonia239
  • Pyrexia (named in the label)238
  • Asthenia236
  • Hypertension (named in the label)234

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms

What next?

Salmeterol: the full record
label, generics, price, shortages, recalls
Side effects hub
the most reported medicines and reactions